DRTB
Patient Stories: Ensuring recovery through timely, accurate drug-resistant tuberculosis testing
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
From Nhlangano to the Future, MSF’s legacy in Shiselweni region: 5 key facts about MSF in Eswatini
MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug
Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
Between life and living: Patients with drug-resistant tuberculosis (DR-TB) share stories of strength, support and suffering
Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives
